Symptom effects
In three studies (Murray et al., 1998; Robion et al., 2001; Céleste et
al., 2005), the authors determined if corticosteroids injected in normal
joints would cause any drawbacks, such as signs of lameness or joint
effusion. No significant changes regarding these outcomes were found
after injections of MPA or TA.